NIH, Partners Commit $74.9M to New Phase of Alzheimer's Program
AMP AD 2.0 will look to bring precision medicine technologies to Alzheimer's biomarker and target discovery over the next five year.
Sage Bionetworks Executive Urges Adoption of Standards to Create 'Open Science'
At Bio-IT World, Sage Bionetworks' John Wilbanks called on the research community to adopt the OMOP and FHIR standards so data becomes more useful to other scientists.
Researchers used CRISPR to engineer mice that have multiple genetic variants associated with late-onset AD to facilitate research into biomarkers and treatments.
The Genomics Evidence Neoplasia Information Exchange aims to provide insights through the analysis of data from tens if not hundreds of thousands of patient results.
Cancer Research Institute, Parker Institute Launch Cancer Neoantigen Research Consortium
The institutes are also collaborating with 30 research groups in academia and industry, and have tapped Sage Bionetworks to handle data analysis.